CLYDE EPPS: Open Payments
NPI 1174740138 · MAXTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 85 payments from 14 companies in 2025. Trend: 2023 $1,878 · 2024 $1,789 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $251 |
| Janssen Pharmaceuticals, Inc | 7 | $241 |
| E.R. Squibb & Sons, L.L.C. | 15 | $178 |
| Otsuka America Pharmaceutical, Inc. | 11 | $169 |
| ABBVIE INC. | 25 | $154 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Alkermes, Inc. | 2 | $35 |
| Luye Pharma (USA) Ltd. | 2 | $33 |
| Abbott Laboratories | 1 | $24 |
Products named: INVEGA SUSTENNA, COBENFY, VRAYLAR, HETLIOZ, FANAPT, ABILIFY ASIMTUFII, Qelbree, Auvelity.
Industry payments across NC — which companies pay providers there.
